If you are having trouble viewing this email, click here
Boston BioFlash

Sponsored by

March 4, 2016

Sanofi Genzyme to begin late-stage trial of new drug for Pompe disease by summer

Pompe affects about 50,000 people around the world, and was popularized by the 2010 movie, “Extraordinary Measures” starring Brendan Fraser and Harrison Ford.

 

Is it a drug or is it a Pokemon? A new quiz for the 20th anniversary

In honor of the 20th anniversary of Pokemon we’ve come up with a new quiz featuring of 12 names, six of which refer to drugs just approved in the past couple years, and the rest that correspond to Pokemon. See if you can distinguish between the two.

 

Startup makes super-simple smartwatch to help care for aging parents

In the past year since it was founded, the company has won or finished toward to top of the field in a half-dozen contests.

 

State commission readies to tighten screws on health care spending in Massachusetts

Organizations selected for an improvement plan will have to identify strategies for improvement over the following 18 months or else face a fine of up to $500,000.

 

Boston Business Journal Science & Tech Newsletters

Don Seiffert

BioFlash Editor

dseiffert@bizjournals.com

617-316-3271

Connect with us

News from the BBJ

National Technology News

Here's what worries investors who give VCs billions to find next big thing

Side effects worry investors of Aerie Pharmaceuticals

Cancel Email Subscription

You may change your email address, your preferences, or unsubscribe from this email at any time by visiting bizjournals.com: https://www.bizjournals.com/account/

If you need other assistance, please let us know or contact: bizjournals.com customer service, bizjournals 120 W. Morehead St., Charlotte, North Carolina 28202

The Business Journals | Latest News | Advertise | Contact Info | Subscribe to Print Edition

© 2016 American City Business Journals, Inc. and its licensors. All rights reserved. The material on this may not be reproduced, distributed, transmitted, cached or otherwise used, except with the written permission of bizjournals.